Cutler Group’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$13K 3776
2022
Q4
$13K Buy
+1,500
New +$16K ﹤0.01% 2507
2022
Q2
Sell
-1,709
Closed -$16.2K 4955
2022
Q1
$21K Buy
+1,709
New +$21K ﹤0.01% 3000
2021
Q4
Sell
-2,500
Closed -$47.5K 5357
2021
Q3
$44K Buy
+2,500
New +$49.8K ﹤0.01% 2612
2019
Q2
Sell
-500
Closed -$1K 4198
2019
Q1
$1K Sell
500
-263
-34% -$628 ﹤0.01% 3597
2018
Q4
$1K Hold
763
﹤0.01% 3554
2018
Q3
$2K Hold
763
﹤0.01% 3444
2018
Q2
$1K Sell
763
-1,450
-66% -$4.05K ﹤0.01% 3756
2018
Q1
$6K Sell
2,213
-837
-27% -$2.37K ﹤0.01% 3136
2017
Q4
$9K Sell
3,050
-14,489
-83% -$57K ﹤0.01% 3188
2017
Q3
$72K Buy
17,539
+5,397
+44% +$24K ﹤0.01% 1928
2017
Q2
$64K Buy
12,142
+6,795
+127% +$39.3K ﹤0.01% 2245
2017
Q1
$30K Sell
5,347
-4,403
-45% -$22.7K ﹤0.01% 2887
2016
Q4
$38K Buy
9,750
+5,933
+155% +$21.1K ﹤0.01% 2817
2016
Q3
$13K Sell
3,817
-5,322
-58% -$22.4K ﹤0.01% 3872
2016
Q2
$55K Buy
9,139
+1,900
+26% +$9.18K ﹤0.01% 2251
2016
Q1
$35K Buy
7,239
+6,639
+1,107% +$29.2K ﹤0.01% 2686
2015
Q4
$3K Buy
+600
New +$4.27K ﹤0.01% 5222

Other funds holding AVXL

Cutler Group's AVXL Position: Q1 2023 in Review

Cutler Group sold out of Anavex Life Sciences (AVXL) in Q1 2023, closing a stake of 1,500 shares — an estimated $13K sold.

Cutler Group first reported a position in AVXL in Q4 2015 and held it in 17 quarters. The position peaked at $72K in Q3 2017. 141 funds tracked by Wall St. Rank hold AVXL as of Q1 2023.

  • Cutler Group reported no remaining Anavex Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 1,500 Anavex Life Sciences shares in Q1 2023, an estimated $13K.
  • Cutler Group first reported a position in Anavex Life Sciences in Q4 2015 and held it in 17 quarters.
  • Cutler Group's Anavex Life Sciences position peaked at $72K in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.